IGF1 and Alzheimer disease: However, a meta-analysis from our lab (ZP Feng) was not able to conclusively determine whether there was an increase or decrease in IGF-1 levels in AD subjects, indicating that IGF-1 may not be the source of microvascular dysfunction in AD (Ostrowski et al., 2016).